APA citiranje

Amengual, J. E., Johannet, P., Lombardo, M., Zullo, K., Hoehn, D., Bhagat, G., . . . O’Connor, O. A. (2015). Dual targeting of protein degradation pathways with the selective HDAC6 inhibitor, ACY-1215, and bortezomib is synergistic in lymphoma. Clin Cancer Res.

Citação norma Chicago

Amengual, Jennifer E., et al. "Dual Targeting of Protein Degradation Pathways With the Selective HDAC6 Inhibitor, ACY-1215, and Bortezomib Is Synergistic in Lymphoma." Clin Cancer Res 2015.

MLA citiranje

Amengual, Jennifer E., et al. "Dual Targeting of Protein Degradation Pathways With the Selective HDAC6 Inhibitor, ACY-1215, and Bortezomib Is Synergistic in Lymphoma." Clin Cancer Res 2015.